Please assess the completion status of the following clinical trial:

Trial Title: Effectiveness and Feasibility of Patient Controlled Analgesia in the ED

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Age 18 to 65~2. Patient deemed by the ED attending physician to require IV opioid analgesia for pain and for whom the ED Attending Physician would consider using PCA~Exclusion Criteria:~1. Patients requiring initial resuscitation that would preclude the use of PCA~2. Long-term use of prescription or non-prescription opioids now or within the past year~3. Recent opioid use within the past 24 hours~4. Chronic pain syndromes~5. Clinician suspicion of current or past opioid dependence/abuse~6. Altered mental status/Clinical suspicion of intoxication~7. Patients expected to require conscious sedation while in the ED~8. Pregnancy or breast-feeding~9. History of chronic obstructive pulmonary disease, history of sleep apnea syndrome, baseline oxygen saturation (room air) \< 97%~10. Systolic blood pressure \< 100 mm Hg~11. Use of sedative medications e.g. benzodiazepines, monoamine oxidase inhibitors, phenothiazines, or tricyclic antidepressants.~12. History of renal insufficiency/renal failure~13. Prior allergic reaction to morphine~14. Inability to provide informed consent or inability to understand or operate PCA device~15. Previous entry of patient into study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Patient Controlled Analgesia (Type: EXPERIMENTAL): PCA (loading dose 0.1 mg/kg morphine and demand dose of 1 mg morphine available every 6 minutes)
- Usual Care (Type: ACTIVE_COMPARATOR): Usual opioid analgesia determined by the provider

Based on this trial design, predict the completion outcome and termination type (if applicable).